Literature DB >> 7717446

Pulmonary alveolar proteinosis. A spontaneous and inducible disease in immunodeficient germ-free mice.

T Warner1, E Balish.   

Abstract

Spontaneous pulmonary alveolar proteinosis (PAP), which resembles human PAP, was found in aging (35 to 40 weeks) germ-free SCID-beige (scid/scid-bg/bg) mice. Spontaneous PAP was not observed in germ-free SCID mice. We describe the induction of PAP in SCID mice monoassociated with a pure culture of Candida albicans for 15 to 40 weeks. The gastrointestinal tracts only are colonized, and disseminated or pulmonary candidiasis does not occur. Another spontaneous form of PAP, designated type II, was discovered in germ-free beige (bg/bg and bg/+) mice and in beige-nude (bg/bg-nu/nu) mice. In this form of PAP, macrophages appear to be unable to digest the ingested phospholipoprotein complex and then accumulate in the alveolar spaces. These murine models should prove useful in elucidating the relationships between immune deficiencies, infections, and cytokine regulation of granulocyte and macrophage production and function in pulmonary alveolar proteinosis.

Entities:  

Mesh:

Year:  1995        PMID: 7717446      PMCID: PMC1869265     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

1.  Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism.

Authors:  G J Bancroft; M J Bosma; G C Bosma; E R Unanue
Journal:  J Immunol       Date:  1986-07-01       Impact factor: 5.422

2.  Association of chlorphentermine with phospholipids in rat alveolar lavage materials, alveolar macrophages and type II cells.

Authors:  J Y Ma; J K Ma; K C Weber; L Bowman; M J Reasor; P R Miles
Journal:  Biochim Biophys Acta       Date:  1988-02-04

3.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-1984. A young woman from Trinidad with interstitial pulmonary disease, hypercalcemia, and lymphocytosis.

Authors: 
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

4.  A T cell-independent mechanism of macrophage activation by interferon-gamma.

Authors:  G J Bancroft; R D Schreiber; G C Bosma; M J Bosma; E R Unanue
Journal:  J Immunol       Date:  1987-08-15       Impact factor: 5.422

5.  Secondary pulmonary alveolar proteinosis occurring in two patients with acquired immune deficiency syndrome.

Authors:  F L Ruben; T S Talamo
Journal:  Am J Med       Date:  1986-06       Impact factor: 4.965

Review 6.  Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review.

Authors:  U B Prakash; S S Barham; H A Carpenter; D E Dines; H M Marsh
Journal:  Mayo Clin Proc       Date:  1987-06       Impact factor: 7.616

7.  Classification and morphometric quantitation of insoluble materials from the lungs of patients with alveolar proteinosis.

Authors:  L B Gilmore; F A Talley; G E Hook
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

8.  Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  S Mahanty; R A Greenfield; W A Joyce; P W Kincade
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Severe combined immunodeficiency (SCID) in the mouse. Pathology, reconstitution, neoplasms.

Authors:  R P Custer; G C Bosma; M J Bosma
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

10.  Pulmonary alveolar proteinosis. Staining for surfactant apoprotein in alveolar proteinosis and in conditions simulating it.

Authors:  G Singh; S L Katyal; C W Bedrossian; R M Rogers
Journal:  Chest       Date:  1983-01       Impact factor: 9.410

View more
  2 in total

1.  Management of pulmonary alveolar proteinosis by repeated bronchoalveolar lavage.

Authors:  R I Simpson; M A Ramsay; M W Millard; J E Capehart
Journal:  Proc (Bayl Univ Med Cent)       Date:  2000-04

Review 2.  Secondary alveolar proteinosis in cancer patients.

Authors:  S Ladeb; J Fleury-Feith; E Escudier; J Tran Van Nhieu; J F Bernaudin; C Cordonnier
Journal:  Support Care Cancer       Date:  1996-11       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.